XCELERATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.035 USD | +4.79% |
|
0.00% | -2.78% |
| 2023 | Xcelerate Inc. has filed an IPO in the amount of $17.25 million. | CI |
| 2023 | Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications | CI |
Financials (USD)
| Sales 2021 | - | Sales 2022 | - | Capitalization | 13.35M |
|---|---|---|---|---|---|
| Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 | - |
| Net Debt 2021 | 165K | Net Debt 2022 | 113K | EV / Sales 2022 | - |
| P/E ratio 2021 |
-108
x | P/E ratio 2022 |
-16
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 58.39% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.79% | ||
| Current month | -7.16% | ||
| 1 month | -12.06% | ||
| 3 months | -40.17% | ||
| 6 months | -30.00% | ||
| Current year | -2.78% |
1 week
0.03
0.04
1 month
0.030.04
Current year
0.030.06
1 year
0.030.14
3 years
0.020.15
5 years
0.000.17
10 years
0.000.17
| Managers | Title | Age | Since |
|---|---|---|---|
Michael O'Shea
CEO | Chief Executive Officer | - | 20-04-30 |
Anja Glisovic
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael O'Shea
CEO | Chief Executive Officer | - | 20-04-30 |
Steve Gravely
BRD | Director/Board Member | - | 20-07-22 |
| Director/Board Member | - | 20-08-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.035 | +4.79% | 214,990 |
| 24-04-22 | 0.0334 | -10.46% | 123,471 |
| 24-04-18 | 0.0373 | +1.47% | 240,045 |
| 24-04-17 | 0.0368 | +5.06% | 29,538 |
| 24-04-16 | 0.035 | -0.46% | 10,617 |
Delayed Quote OTC Markets, April 23, 2024 at 03:42 pm EDT
More quotes
Xcelerate, Inc. seeks to acquire technology/healthcare business. The Companyâs business plan encompasses three separate but related businesses within the medical, health and wellness sectors, including owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; formulation, packaging and marketing of over the counter, clinically tested skin care products, and development of virtual health technology to assist patients in developing countries, initially in Africa, to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.78% | 15.21M | |
| -13.25% | 86.34B | |
| +18.01% | 84.49B | |
| +11.97% | 29.68B | |
| -8.50% | 17.5B | |
| -0.89% | 16.67B | |
| -2.10% | 12.71B | |
| +4.43% | 12.53B | |
| -30.70% | 11.89B | |
| +27.83% | 11.74B |
- Stock Market
- Equities
- XCRT Stock
